HomeComparePNNT vs SYK

PNNT vs SYK: Dividend Comparison 2026

PNNT yields 21.82% · SYK yields 1.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PNNT wins by $2487.08M in total portfolio value
10 years
PNNT
PNNT
● Live price
21.82%
Share price
$4.40
Annual div
$0.96
5Y div CAGR
57.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2487.12M
Annual income
$2,270,557,040.91
Full PNNT calculator →
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →

Portfolio growth — PNNT vs SYK

📍 PNNT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPNNTSYK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PNNT + SYK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PNNT pays
SYK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PNNT
Annual income on $10K today (after 15% tax)
$1,854.55/yr
After 10yr DRIP, annual income (after tax)
$1,929,973,484.77/yr
SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
At 15% tax rate, PNNT beats the other by $1,929,966,444.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PNNT + SYK for your $10,000?

PNNT: 50%SYK: 50%
100% SYK50/50100% PNNT
Portfolio after 10yr
$1243.58M
Annual income
$1,135,282,661.94/yr
Blended yield
91.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

PNNT
Analyst Ratings
3
Buy
11
Hold
1
Sell
Consensus: Hold
Price Target
$6.17
+40.2% upside vs current
Range: $5.50 — $7.00
Altman Z
-0.1
Piotroski
6/9
SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PNNT buys
0
SYK buys
0
No recent congressional trades found for PNNT or SYK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPNNTSYK
Forward yield21.82%1.04%
Annual dividend / share$0.96$3.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR57.6%46.2%
Portfolio after 10y$2487.12M$43.3K
Annual income after 10y$2,270,557,040.91$8,282.98
Total dividends collected$2470.97M$21.0K
Payment frequencyquarterlyquarterly
SectorBDCHealthcare
Analyst consensusHoldBuy
Analyst price target$6.17$428.67

Year-by-year: PNNT vs SYK ($10,000, DRIP)

YearPNNT PortfolioPNNT Income/yrSYK PortfolioSYK Income/yrGap
1← crossover$14,139$3,438.55$10,852$152.43+$3.3KPNNT
2$22,289$7,160.64$11,838$226.03+$10.5KPNNT
3$40,476$16,626.77$13,004$336.89+$27.5KPNNT
4$87,781$44,472.18$14,420$505.63+$73.4KPNNT
5$235,984$142,058.38$16,195$766.09+$219.8KPNNT
6$815,001$562,497.15$18,504$1,175.64+$796.5KPNNT
7$3,733,376$2,861,325.49$21,635$1,835.40+$3.71MPNNT
8$23,300,323$19,305,611.09$26,082$2,932.10+$23.27MPNNT
9$202,397,772$177,466,426.06$32,737$4,829.68+$202.37MPNNT
10$2,487,122,657$2,270,557,040.91$43,312$8,282.98+$2487.08MPNNT

PNNT vs SYK: Complete Analysis 2026

PNNTBDC

PennantPark Investment Corporation, a business development company is a private equity fund specializes in direct and mezzanine investments in middle market companies. It invests in the form of mezzanine debt, senior secured loans, and equity investments. The fund typically invests in buildings and real estate, hotels, gaming and leisure, technology, telecommunications, transportation, information technology services, electronics, healthcare & pharmaceuticals, education and childcare, financial services, printing and publishing, consumer products, business services, energy & Related Services and utilities, distribution, oil and gas, media, environmental services, aerospace and defense, building materials, capital equipment, chemicals, plastics, & rubber, food & beverage, wholesale, manufacturing and basic industries and retail. It invests in equity securities and debt transactions through preferred stock, common stock, warrants, options, senior secured debt, subordinated debt, subordinated loans, first lien debt, mezzanine loans, and distressed debt securities and private equity co-investments. It seeks to invest in companies based in the United States. The fund seeks to invest between $10 million and $100 million cross the capital structure (senior secured loans, subordinated debt, and other investments) in its portfolio companies with EBITDA between $10 to $50 million. Its mezzanine loans, senior secured loans, and other investments in its portfolio companies are between $15 million and $50 million. The fund may also make non-control equity and debt investments.

Full PNNT Calculator →

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →
📬

Get this PNNT vs SYK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PNNT vs SCHDPNNT vs JEPIPNNT vs OPNNT vs KOPNNT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.